Form 4 for KYMR Kymera Therapeutics, Inc.
Accepted 2021-08-19 00:00:00 ET · period of report 2021-08-17 · accession 0000899243-21-033638 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-08-19 | 2021-08-17 | KYMR | Chesworth Richard | CSO | S - Sale+OE | $50.37 | -54.0K | 45.2K | -54% | -$2.72M |
| D | 2021-08-19 | 2021-08-17 | KYMR | Chesworth Richard | CSO | M - OptEx | $20.00 | +54.0K | 54.0K | New | +$1.08M |
| D | 2021-08-19 | 2021-08-17 | KYMR | Chesworth Richard | CSO | M - OptEx | $0.00 | -54.0K | 297.1K | -15% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-17 | S | D | 288 | $52.09 | 0 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $52.06 to $52.16. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 2 | Common | Common Stock | 2021-08-17 | S | D | 2,928 | $51.68 | 288 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $51.05 to $52.00. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 3 | Common | Common Stock | 2021-08-17 | S | D | 41,975 | $50.37 | 3,216 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $50.04 to $51.02. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 4 | Common | Common Stock | 2021-08-17 | S | D | 8,809 | $49.90 | 45,191 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $49.04 to $50.03. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. |
| 5 | Common | Common Stock | 2021-08-17 | M | A | 54,000 | $20.00 | 54,000 | D | — | — | |
| 6 | Derivative | Stock Option (Right to Buy) | 2021-08-17 | M | D | 54,000 | $0.00 | 297,119 | D | $20.00 · — to 2030-08-19 | 54,000 Common Stock | (F6) Twenty-five percent (25%) of the shares subject to this option vested and became exercisable on August 17, 2021, and the remainder of the shares shall vest in equal monthly installments for a period of thirty-six (36) months thereafter. |